INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 130 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 2.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,626,750 | +563.6% | 237,500 | +705.8% | 0.01% | +500.0% |
| Q1 2023 | $395,849 | +48.6% | 29,475 | +36.9% | 0.00% | – |
| Q4 2022 | $266,326 | -66.3% | 21,530 | -62.0% | 0.00% | -100.0% |
| Q3 2022 | $790,000 | -4.5% | 56,590 | -5.5% | 0.00% | 0.0% |
| Q2 2022 | $827,000 | -83.5% | 59,900 | -80.6% | 0.00% | -80.0% |
| Q4 2021 | $5,024,000 | +9.7% | 308,400 | -0.0% | 0.01% | +66.7% |
| Q3 2021 | $4,579,000 | -11.3% | 308,416 | +19.3% | 0.00% | -25.0% |
| Q2 2021 | $5,163,000 | -4.4% | 258,493 | +10.5% | 0.00% | -20.0% |
| Q1 2021 | $5,400,000 | -18.6% | 233,960 | -12.9% | 0.01% | 0.0% |
| Q4 2020 | $6,631,000 | -31.9% | 268,638 | +14.3% | 0.01% | -37.5% |
| Q3 2020 | $9,737,000 | -10.9% | 234,970 | +3.0% | 0.01% | -38.5% |
| Q2 2020 | $10,933,000 | +0.7% | 228,108 | +32.2% | 0.01% | -7.1% |
| Q1 2020 | $10,861,000 | +762.7% | 172,518 | +1597.5% | 0.01% | +1300.0% |
| Q4 2019 | $1,259,000 | +20.8% | 10,163 | -35.3% | 0.00% | 0.0% |
| Q3 2019 | $1,042,000 | -3.7% | 15,701 | +15.5% | 0.00% | 0.0% |
| Q2 2019 | $1,082,000 | +63.0% | 13,592 | +128.9% | 0.00% | 0.0% |
| Q1 2019 | $664,000 | -81.9% | 5,937 | -83.7% | 0.00% | -80.0% |
| Q4 2018 | $3,662,000 | +176.2% | 36,330 | +246.0% | 0.01% | +150.0% |
| Q3 2018 | $1,326,000 | +8740.0% | 10,500 | +5701.1% | 0.00% | – |
| Q2 2018 | $15,000 | -88.5% | 181 | -91.9% | 0.00% | – |
| Q4 2017 | $130,000 | -96.3% | 2,233 | -96.3% | 0.00% | -100.0% |
| Q3 2017 | $3,482,000 | +541.3% | 60,000 | +1100.0% | 0.01% | +500.0% |
| Q4 2016 | $543,000 | -34.0% | 5,000 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $823,000 | +15.4% | 5,000 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $713,000 | -81.3% | 5,000 | -80.4% | 0.00% | -87.5% |
| Q4 2015 | $3,804,000 | – | 25,471 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $9,514,000 | 1.49% |
| CM Management, LLC | 45,000 | $668,000 | 0.50% |
| EULAV Asset Management | 660,000 | $9,801,000 | 0.26% |
| DLD Asset Management, LP | 225,200 | $3,346,000 | 0.24% |
| Virtus ETF Advisers LLC | 21,387 | $318,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 79,145 | $1,175,000 | 0.12% |
| Hennion & Walsh Asset Management, Inc. | 136,720 | $2,030,000 | 0.11% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $2,507,000 | 0.08% |
| Inspire Investing, LLC | 31,868 | $473,000 | 0.06% |
| DUALITY ADVISERS, LP | 51,196 | $760,000 | 0.06% |